Integration of Machine Learning With PBPK and QSAR Modeling Approaches to Facilitate Drug Discovery and Development
CPT: Pharmacometrics & Systems Pharmacology · 2026-04 · 15 (4)
DOI: 10.1002/psp4.70228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 25.03.2026. Verfasst von Xinyue Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Quantitative Structure-Activity Relationship, Machine Learning, Drug Discovery, Models, Biological. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS.
Abstract (Originalsprache)
This review examines the application of machine learning (ML) in physiologically based pharmacokinetic (PBPK) modeling through improved prediction of input parameters, particularly via quantitative structure–activity relationship (QSAR) models, for absorption, distribution, metabolism, and excretion (ADME) properties across drug development phases. Traditional PBPK models, while mechanistically sound, face limitations in applicability domain when compound‐specific physicochemical and biochemical parameters (e.g., partition coefficients, metabolic clearance rates, plasma protein binding) cannot be reliably determined or estimated for novel chemicals. ML‐enhanced QSAR models address these input parameter limitations by predicting required parameters directly from chemical structure, thereby extending PBPK applicability to diverse chemical space without altering the mechanistic model framework itself. Recent advances in ML‐powered QSAR methodology generate higher‐quality predictions of partition coefficients, clearance rates, and binding parameters. When these ML‐predicted parameters are integrated as inputs into conventional PBPK frameworks, the resulting simulations often demonstrate significantly improved predictive accuracy compared to PBPK models using conventional regression‐based QSAR inputs. This workflow—wherein ML enhances QSAR prediction quality, which subsequently improves PBPK simulation reliability through better input parameters—facilitates critical drug discovery and development decisions, from early candidate selection to clinical translation and safety assessment, potentially reducing pharmacokinetic‐related drug candidate failures. However, challenges remain, including limited chemical diversity in QSAR training data sets, model interpretability concerns, and evolving regulatory considerations for ML‐derived parameters in PBPK submissions. Future developments point toward seamless integration of ML‐enhanced QSAR predictions as validated inputs for mechanistic PBPK models through standardized validation approaches and collaboration among academia, industry, and regulatory bodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
- Center for Environmental and Human Toxicology, University of Florida, Gainesville, Florida, USA.
- Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, Florida, USA.
ORCID-Profile: Xinyue Chen, Zhoumeng Lin
Förderung
- NIBIB NIH HHS
Zitieren
APA
Chen, X., & Lin, Z. (2026). Integration of Machine Learning With PBPK and QSAR Modeling Approaches to Facilitate Drug Discovery and Development. CPT: Pharmacometrics & Systems Pharmacology, 15(4). https://doi.org/10.1002/psp4.70228
Vancouver
Chen X, Lin Z. Integration of Machine Learning With PBPK and QSAR Modeling Approaches to Facilitate Drug Discovery and Development. CPT: Pharmacometrics & Systems Pharmacology. 2026;15(4). doi:10.1002/psp4.70228
BibTeX
@article{Chen2026,
author = {Chen, Xinyue and Lin, Zhoumeng},
title = {Integration of Machine Learning With PBPK and QSAR Modeling Approaches to Facilitate Drug Discovery and Development},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/psp4.70228}
}
EUVIMED